Direct Thrombin Inhibitors May Have A Decreased Risk Of Intracerebral Hemorrhage Compared With Older Anticoagulants (I2-2.005)

CONCLUSIONS: We found no significant difference in risk of ICH with DTI compared to the AC group and a trend towards lower risk with DTI. Future studies with larger numbers on DTIs are needed to confirm differences in ICH risk between DTIs and other anticoagulants.Disclosure: Dr. Ravipati has nothing to disclose. Dr. Woo has received research support from the National Institutes of Health. Dr. Sekar has received research support from the National Institutes of Health. Dr. Moomaw has received research support from the National Institutes of Health. Dr. Flaherty has received personal compensation for activities with CSL Behring as a consultant and member of an advisory board. Dr. Flaherty has received research support from the National Institute of Neurological Disorders and Stroke, and Novo Nordisk. Dr. Osborne has received research support from the National Institutes of Health.

Source: Neurology - April 9, 2014 Category: Neurology Authors: Ravipati, S., Woo, D., Sekar, P., Moomaw, C., Flaherty, M., Osborne, J. Tags: New Antithrombotic Agents for Stroke Prevention Data Blitz Presentations Source Type: research